TORONTO, May 2, 2024
/CNW/ - Hypothesis, an important new magazine for the life
sciences industry, is now available online and in print. Catalytic
Health, Canada's largest
independent medical publisher, is launching the thrice-yearly
publication to both inspire and inform people who work in the
pharmaceutical, medical device, and biotech fields in Canada.
With news, features, and interviews with patients, physicians,
researchers and industry movers and shakers, Hypothesis
offers a breadth of voices on relevant and timely industry topics.
These include challenges to accessing medications in Canada, advocacy, marketing strategies, and
new product news. Hypothesis will also include big picture
perspectives on how technologies like AI and breakthroughs in gene
editing, obesity treatment, and more are shaping the industry.
"Through Hypothesis, Catalytic Health is proud to be able
to spotlight the impressive growth and exciting innovation in
Canada's life sciences industry,
while sharing news, strategies, and inspirational stories,"
explains Rohit Khanna, president and
managing director of Catalytic Health.
To register for digital and/or print issues for
Hypothesis, please visit: hypothesismag.com.
About Catalytic Health
One of Canada's leading medical
communications firms, Catalytic Health is the country's largest
independent medical publisher, one of Canada's largest scientific conference
providers, and a leader in innovative events and services for the
life sciences industry.
SOURCE Catalytic Health